Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

DowDuPont (DWDP) Rating Dropped to Buy

By Portfolio Grader
The current recommendation of Buy for DowDuPont Inc (NULL:DWDP) is the result of using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. The shares have been downgraded from a Strong Buy to a Buy in the last week.

AstraZeneca’s (AZN) Stock Has Sell Ranking Reaffirmed

By Portfolio Grader
Currently, AstraZeneca Plc (NYSE:AZN) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. AZN has maintained this ranking for 2 months.

Eli Lilly (LLY) Hold Ranking Retained

By Portfolio Grader
Eli Lilly and Company (NYSE:LLY) is ranked as a Hold using the methods for investing of Louis Navellier and his Portfolio Grader stock evaluator. LLY has maintained this ranking for 6 months.

Novo Nordisk A/S’s (NVO) Stock Has Hold Recommendation Remain in Place

By Portfolio Grader
Portfolio Grader currently ranks Novo Nordisk A/S (NYSE:NVO) a Hold. The approach to investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Schlumberger (SLB) Shares Rated a Sell

By Portfolio Grader
Currently, Schlumberger NV (NYSE:SLB) has a Sell using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. SLB has maintained this ranking for 2 months.

GlaxoSmithKline (GSK) Keeps Sell Recommendation

By Portfolio Grader
Currently, GlaxoSmithKline Plc (NYSE:GSK) has a Sell using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. GSK has maintained this ranking for 2 months.

Bristol-Myers Squibb Co (BMY) Stock Raised to Hold

By Portfolio Grader
Portfolio Grader currently ranks Bristol-Myers Squibb Co (NYSE:BMY) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The shares have been upgraded from a Sell to a Hold in the last week.

Analytics Keep Sanofi (SNY) Strong Buy Ranking

By Portfolio Grader
Currently, Sanofi SA (NYSE:SNY) has a Strong Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. This represents no change from the previous week and is the same ranking SNY has had from Portfolio Grader for the last month.

The Facebook Inc (FB) Stock Price May Have Hit a Peak for Now

By Josh Enomoto, InvestorPlace Contributor
The FB stock price benefit from years of remarkable bullishness, but even this social-media giant needs a rest every now and then.

Shares of BP (BP) Recommended as a Hold

By Portfolio Grader
BP Plc (NYSE:BP) is ranked as a Hold using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BP has had from Portfolio Grader for 3 months.

Total (TOT) Shares Upgraded to Buy

By Portfolio Grader
The current recommendation of Buy for Total SA (NYSE:TOT) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Royal Dutch Shell (RDS.A) Stock Raised to Strong Buy from a Buy

By Portfolio Grader
The current recommendation of Strong Buy for Royal Dutch Shell Plc (NYSE:RDS.A) is the result of using the methods for investing of Louis Navellier and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Merck & Co’s (MRK) Raised to Hold

By Portfolio Grader
Merck & Co (NYSE:MRK) is ranked as a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Snap Inc (SNAP) Stock Continues to Baffle the Haters

By James Brumley, InvestorPlace Feature Writer
SNAP stock is a lousy investment, but Snapchat has unveiled a couple of key psychological principles we should all take note of.

Novartis AG’s (NVS) Hold Rating Affirmed

By Portfolio Grader
The current recommendation of Hold for Novartis AG (NYSE:NVS) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking NVS has had from Portfolio Grader for the last month.

Shares of Verizon (VZ) Maintain Hold Recommendation

By Portfolio Grader
Portfolio Grader currently ranks Verizon Communication Inc (NYSE:VZ) a Hold. With unique fundamental and quantitative metrics developed by Louis Navellier, this analytical tool researches nearly 5,000 stocks weekly. This represents no change from the previous week and is the same ranking VZ has had from Portfolio Grader for the last month.

China Mobile (CHL) Raised to Hold from a Sell

By Portfolio Grader
China Mobile Ltd (NYSE:CHL) is ranked as a Hold using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Pfizer (PFE) Sell Ranking Confirmed

By Portfolio Grader
Pfizer Inc (NYSE:PFE) is ranked as a Sell using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking PFE has had from Portfolio Grader for the last month.

Buy Rating for Chevron (CVX) Reaffirmed

By Portfolio Grader
The current recommendation of Buy for Chevron Corp (NYSE:CVX) is derived using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 2 months.
Load More Articles